Lysophosphatidic acid 2 receptor-mediated supramolecular complex formation regulates its antiapoptotic effect

E. Shuyu, Yun Ju Lai, Ryoko Tsukahara, Chen Shan Chen, Yuko Fujiwara, Junming Yue, Jei Hwa Yu, Huazhang Guo, Akio Kihara, Gábor Tigyi, Fang Tsyr Lin

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

The G protein-coupled lysophosphatidic acid 2 (LPA2) receptor elicits prosurvival responses to prevent and rescue cells from apoptosis. However, G protein-coupled signals are not sufficient for the full protective effect of LPA2. LPA2 differs from other LPA receptor subtypes in the C-terminal tail, where it contains a zinc finger-binding motif for the interactions with LIM domain-containing TRIP6 and proapoptotic Siva-1, and a PDZ-binding motif through which it complexes with the NHERF2 scaffold protein. In this report, we identify a unique CXXC motif of LPA2 responsible for the binding to TRIP6 and Siva-1, and demonstrate that disruption of these macromolecular complexes or knockdown of TRIP6 or NHERF2 expression attenuates LPA2-mediated protection from chemotherapeutic agent-induced apoptosis. In contrast, knockdown of Siva-1 expression enhances this effect. Furthermore, a PDZ-mediated direct interaction between TRIP6 and NHERF2 facilitates their interaction with LPA2. Together, these results suggest that in addition to G protein-activated signals, the cooperation embedded in the LPA2-TRIP6-NHERF2 ternary complex provides a novel ligand-dependent signal amplification mechanism that is required for LPA2-mediated full activation of antiapoptotic signaling.

Original languageEnglish
Pages (from-to)14558-14571
Number of pages14
JournalJournal of Biological Chemistry
Volume284
Issue number21
DOIs
Publication statusPublished - 2009 May 22

Fingerprint

Lysophosphatidic Acid Receptors
GTP-Binding Proteins
Apoptosis
Macromolecular Substances
Zinc Fingers
lysophosphatidic acid
Scaffolds
Amplification
Zinc
Ligands
Chemical activation

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Lysophosphatidic acid 2 receptor-mediated supramolecular complex formation regulates its antiapoptotic effect. / Shuyu, E.; Lai, Yun Ju; Tsukahara, Ryoko; Chen, Chen Shan; Fujiwara, Yuko; Yue, Junming; Yu, Jei Hwa; Guo, Huazhang; Kihara, Akio; Tigyi, Gábor; Lin, Fang Tsyr.

In: Journal of Biological Chemistry, Vol. 284, No. 21, 22.05.2009, p. 14558-14571.

Research output: Contribution to journalArticle

Shuyu, E, Lai, YJ, Tsukahara, R, Chen, CS, Fujiwara, Y, Yue, J, Yu, JH, Guo, H, Kihara, A, Tigyi, G & Lin, FT 2009, 'Lysophosphatidic acid 2 receptor-mediated supramolecular complex formation regulates its antiapoptotic effect', Journal of Biological Chemistry, vol. 284, no. 21, pp. 14558-14571. https://doi.org/10.1074/jbc.M900185200
Shuyu, E. ; Lai, Yun Ju ; Tsukahara, Ryoko ; Chen, Chen Shan ; Fujiwara, Yuko ; Yue, Junming ; Yu, Jei Hwa ; Guo, Huazhang ; Kihara, Akio ; Tigyi, Gábor ; Lin, Fang Tsyr. / Lysophosphatidic acid 2 receptor-mediated supramolecular complex formation regulates its antiapoptotic effect. In: Journal of Biological Chemistry. 2009 ; Vol. 284, No. 21. pp. 14558-14571.
@article{902ac3b63c744c06a796340e103365a1,
title = "Lysophosphatidic acid 2 receptor-mediated supramolecular complex formation regulates its antiapoptotic effect",
abstract = "The G protein-coupled lysophosphatidic acid 2 (LPA2) receptor elicits prosurvival responses to prevent and rescue cells from apoptosis. However, G protein-coupled signals are not sufficient for the full protective effect of LPA2. LPA2 differs from other LPA receptor subtypes in the C-terminal tail, where it contains a zinc finger-binding motif for the interactions with LIM domain-containing TRIP6 and proapoptotic Siva-1, and a PDZ-binding motif through which it complexes with the NHERF2 scaffold protein. In this report, we identify a unique CXXC motif of LPA2 responsible for the binding to TRIP6 and Siva-1, and demonstrate that disruption of these macromolecular complexes or knockdown of TRIP6 or NHERF2 expression attenuates LPA2-mediated protection from chemotherapeutic agent-induced apoptosis. In contrast, knockdown of Siva-1 expression enhances this effect. Furthermore, a PDZ-mediated direct interaction between TRIP6 and NHERF2 facilitates their interaction with LPA2. Together, these results suggest that in addition to G protein-activated signals, the cooperation embedded in the LPA2-TRIP6-NHERF2 ternary complex provides a novel ligand-dependent signal amplification mechanism that is required for LPA2-mediated full activation of antiapoptotic signaling.",
author = "E. Shuyu and Lai, {Yun Ju} and Ryoko Tsukahara and Chen, {Chen Shan} and Yuko Fujiwara and Junming Yue and Yu, {Jei Hwa} and Huazhang Guo and Akio Kihara and G{\'a}bor Tigyi and Lin, {Fang Tsyr}",
year = "2009",
month = "5",
day = "22",
doi = "10.1074/jbc.M900185200",
language = "English",
volume = "284",
pages = "14558--14571",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "21",

}

TY - JOUR

T1 - Lysophosphatidic acid 2 receptor-mediated supramolecular complex formation regulates its antiapoptotic effect

AU - Shuyu, E.

AU - Lai, Yun Ju

AU - Tsukahara, Ryoko

AU - Chen, Chen Shan

AU - Fujiwara, Yuko

AU - Yue, Junming

AU - Yu, Jei Hwa

AU - Guo, Huazhang

AU - Kihara, Akio

AU - Tigyi, Gábor

AU - Lin, Fang Tsyr

PY - 2009/5/22

Y1 - 2009/5/22

N2 - The G protein-coupled lysophosphatidic acid 2 (LPA2) receptor elicits prosurvival responses to prevent and rescue cells from apoptosis. However, G protein-coupled signals are not sufficient for the full protective effect of LPA2. LPA2 differs from other LPA receptor subtypes in the C-terminal tail, where it contains a zinc finger-binding motif for the interactions with LIM domain-containing TRIP6 and proapoptotic Siva-1, and a PDZ-binding motif through which it complexes with the NHERF2 scaffold protein. In this report, we identify a unique CXXC motif of LPA2 responsible for the binding to TRIP6 and Siva-1, and demonstrate that disruption of these macromolecular complexes or knockdown of TRIP6 or NHERF2 expression attenuates LPA2-mediated protection from chemotherapeutic agent-induced apoptosis. In contrast, knockdown of Siva-1 expression enhances this effect. Furthermore, a PDZ-mediated direct interaction between TRIP6 and NHERF2 facilitates their interaction with LPA2. Together, these results suggest that in addition to G protein-activated signals, the cooperation embedded in the LPA2-TRIP6-NHERF2 ternary complex provides a novel ligand-dependent signal amplification mechanism that is required for LPA2-mediated full activation of antiapoptotic signaling.

AB - The G protein-coupled lysophosphatidic acid 2 (LPA2) receptor elicits prosurvival responses to prevent and rescue cells from apoptosis. However, G protein-coupled signals are not sufficient for the full protective effect of LPA2. LPA2 differs from other LPA receptor subtypes in the C-terminal tail, where it contains a zinc finger-binding motif for the interactions with LIM domain-containing TRIP6 and proapoptotic Siva-1, and a PDZ-binding motif through which it complexes with the NHERF2 scaffold protein. In this report, we identify a unique CXXC motif of LPA2 responsible for the binding to TRIP6 and Siva-1, and demonstrate that disruption of these macromolecular complexes or knockdown of TRIP6 or NHERF2 expression attenuates LPA2-mediated protection from chemotherapeutic agent-induced apoptosis. In contrast, knockdown of Siva-1 expression enhances this effect. Furthermore, a PDZ-mediated direct interaction between TRIP6 and NHERF2 facilitates their interaction with LPA2. Together, these results suggest that in addition to G protein-activated signals, the cooperation embedded in the LPA2-TRIP6-NHERF2 ternary complex provides a novel ligand-dependent signal amplification mechanism that is required for LPA2-mediated full activation of antiapoptotic signaling.

UR - http://www.scopus.com/inward/record.url?scp=67649817281&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649817281&partnerID=8YFLogxK

U2 - 10.1074/jbc.M900185200

DO - 10.1074/jbc.M900185200

M3 - Article

C2 - 19293149

AN - SCOPUS:67649817281

VL - 284

SP - 14558

EP - 14571

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 21

ER -